Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).

Tito R Mendoza Loretta A WilliamsKaren N KeatingJonathan SiegelCem ElbiAnna K NowakRaffit HassanBrian CuffelCharles S Cleeland

Published in: Journal of patient-reported outcomes (2019)

Symptoms specific to a particular cancer, treatment method, or treatment site can be added to the core MDASI to create a tailored, "fit for purpose" instrument. We found the MDASI-MPM to be a valid, reliable, and responsive (sensitive) instrument for assessing the severity of symptoms of patients with MPM and their interference in patients' daily functioning.

Keyphrases

psychometric properties
patient reported outcomes
end stage renal disease
ejection fraction
newly diagnosed
sleep quality
physical activity
molecular dynamics
drug delivery
patient reported
smoking cessation
replacement therapy